Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in epigenetics and AI-driven Precision Cardiovascular Medicine, Aimil Ltd., a company at the forefront of the ...

April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...

July 24 (Reuters) - Indian diagnostics firm Dr Lal PathLabs on Friday reported a rise in first-quarter profit, boosted ‌by sustained demand for its tests and preventive health ‌packages under the ...

Earnings call Dr. Lal PathLabs reported FY25 revenue of ₹2,461 crore, up 10.5% YoY, with PAT rising 35.9% to ₹492 crore (including a one-time tax benefit). Q4 margins expanded, but FY26 guidance ...

Dr Lal PathLabs - Read all the latest news headline updates on Dr Lal PathLabs. Get all the Dr Lal PathLabs breaking news updates, videos, photostories and more at Business Standard.

Dr Lal PathLabs, one of the largest lab testing companies in India, left a huge cache of patient data on a public server for months, TechCrunch has learned. The lab testing giant, headquartered in New ...

Shares of Dr Lal Path Labs surged in morning trade on Monday after the diagnostics company reported better-than-expected June quarter results. The stock climbed as much as 7.55 percent during the ...

Consolidated net profit for the three months ended ‌June 30 ⁠rose to ⁠1.70 billion rupees ($17.62 million) from 1.32 billion rupees a year earlier. Consolidated net profit for the three months ended ...

Diagnostics firm Dr Lal PathLabs on Friday reported a rise in first-quarter profit, boosted by sustained demand for its tests and preventive health packages under the SwasthFit banner. The company’s ...